# Abzena plc: Form D filings

Abzena plc, a biotechnology company in Cambridge, United Kingdom, filed 2 Form D notices with the SEC in 2015. The latest, on December 23, 2015, reports $3.6 million sold of a $3.6 million offering to 2 investors.

Find out what Abzena plc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Abzena%20plc%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Abzena%20plc&page=%2Fdata%2Fform-d%2Fcompany%2Fabzena-plc-1653673)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Abzena%20plc%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Abzena%20plc&page=%2Fdata%2Fform-d%2Fcompany%2Fabzena-plc-1653673)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: BABRAHAM RESEARCH CAMPUS, BABRAHAM, Cambridge, United Kingdom, CB22
- Phone: 44(0)1223903498
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: United Kingdom
- Year incorporated: 2014
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1653673

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 23, 2015 | New notice | $3,603,185 | $3,603,185 | $0 | 2 | Dec 11, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1653673/000165367315000002/0001653673-15-000002-index.htm) |
| Sep 25, 2015 | New notice | $700,000 | $700,000 | $0 | 7 | Sep 11, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1653673/000165367315000001/0001653673-15-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Jim John Edward Mills | Executive Officer |  |
| Kenneth John Edward Cunningham | Director |  |
| Campbell John Edward Bunce | Executive Officer |  |
| Nareshkumar John Edward Jain | Executive Officer |  |
| Gary John Edward Pierce | Executive Officer |  |
| Anker John Edward Lundemose | Director |  |
| Julian John Edward Smith | Executive Officer, Director |  |
| William John Edward Burt | Executive Officer, Director |  |
| Leigh John Edward Pierce | Executive Officer |  |
| Nigel John Edward Pitchford | Director |  |
| Sally John Edward Waterman | Executive Officer |  |
| Matthew John Edward Baker | Executive Officer |  |
| Peter John Edward Grant | Director |  |
| Anthony John Edward Brampton | Director |  |

[Every Form D from the week of Dec 21, 2015](https://specstream.ai/data/form-d/week/2015-12-21) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Abzena plc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).